| Lestaurtinib |
ENSG00000104691.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000124835.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000157306.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000160336.10 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000160336.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000172965.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000173867.8 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000175061.13 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000175772.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000175873.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000177738.3 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000177993.3 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000178803.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000178947.8 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000179141.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000179406.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000179818.9 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000180712.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000182057.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000182310.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000182366.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000182648.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000183674.7 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000184274.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000185168.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000185186.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000185203.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000185837.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000185837.3 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000186019.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000186056.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000186148.7 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000186594.8 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000188365.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000189223.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000189419.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000196421.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000196756.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000196951.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000197210.7 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000197332.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000197332.7 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000197462.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000203327.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000203496.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000203499.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000203588.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000203588.3 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000203650.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000203875.6 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000203999.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000204362.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000204588.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000204666.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000204802.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000204815.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000204934.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000205054.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000205559.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000205559.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000205559.3 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000205662.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000206417.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000212939.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000214146.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000214432.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000214650.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000214691.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000214733.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000214870.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000214922.5 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000215022.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000215304.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000215304.3 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000215386.6 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000215424.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000215841.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000219665.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000221817.5 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000222041.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000223356.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000223382.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000223393.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000223396.2 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000223401.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000223401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000223442.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000223458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000223461.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000223477.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000223478.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000223522.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000223525.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000223576.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000223617.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000223653.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000223685.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000223695.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000223697.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000223734.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000223749.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000223749.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000223791.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000223797.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000223821.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000223842.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000223960.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000223979.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000224023.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000224032.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000224057.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000224063.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000224074.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000224086.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000224086.3 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000224138.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000224142.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000224238.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000224271.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000224271.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000224292.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000224310.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000224342.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000224363.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000224363.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000224363.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000224376.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000224441.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000224441.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000224468.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000224533.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000224549.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000224577.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000224609.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000224614.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000224621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000224621.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000224623.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000224699.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000224713.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000224746.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000224746.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000224758.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000224761.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000224790.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000224794.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000224799.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000224804.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000224821.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000224822.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000224843.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000224844.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000224846.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000224863.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000224884.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000224884.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000224934.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000224959.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000224959.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000224972.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000224985.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000225028.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000225030.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000225037.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000225077.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000225126.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000225156.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000225180.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000225187.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000225195.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000225218.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000225235.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000225265.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000225335.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000225361.3 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000225439.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000225439.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000225489.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000225506.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000225506.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000225518.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000225527.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000225541.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000225649.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000225675.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000225684.3 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000225703.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000225744.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000225744.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000225744.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000225760.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000225791.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000225839.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000225889.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000225913.2 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000225945.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000225945.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000225948.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000226097.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000226101.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000226179.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000226194.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000226245.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000226251.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000226312.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000226330.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000226332.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000226332.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000226352.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000226375.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000226377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000226440.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000226465.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000226548.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000226604.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000226645.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000226690.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000226756.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000226756.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000226835.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000226835.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000226852.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000226856.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000226869.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000226899.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000226920.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000226920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000226920.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000227014.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000227070.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000227071.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000227200.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000227248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000227279.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000227359.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000227403.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000227403.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000227407.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000227432.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000227456.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000227477.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000227492.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000227533.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000227640.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000227676.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000227695.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000227698.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000227704.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000227773.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000227811.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000227906.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000227946.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000227959.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000227959.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000228021.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000228022.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000228037.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000228150.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000228156.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000228192.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000228223.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000228288.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000228293.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000228352.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000228369.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000228386.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000228386.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000228436.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000228482.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000228526.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000228541.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000228598.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000228649.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000228649.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000228661.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000228661.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000228677.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000228742.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000228748.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000228786.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000228786.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000228817.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000228824.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000228838.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000228886.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000228889.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000228988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000229017.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000229021.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000229043.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000229109.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000229137.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000229192.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000229291.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000229312.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000229368.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000229589.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000229591.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000229692.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000229697.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000229728.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000229750.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000229751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000229766.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000229801.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000229832.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000229839.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000229869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000229891.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000229901.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000229912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000229952.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000229953.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000229989.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000230002.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000230024.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000230046.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000230065.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000230065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000230084.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000230102.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000230337.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000230345.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000230345.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000230408.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000230417.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000230433.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000230489.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000230513.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000230612.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000230630.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000230648.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000230658.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000230724.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000230753.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000230806.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000230815.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000230826.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000230836.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000230839.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000230896.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000230899.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000230925.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000231010.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000231024.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000231050.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000231050.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000231057.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000231064.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000231156.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000231160.5 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000231185.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000231187.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000231201.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000231226.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000231324.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000231329.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000231335.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000231335.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000231422.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000231429.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000231441.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000231551.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000231566.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000231611.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000231689.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000231713.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000231721.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000231728.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000231728.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000231728.2 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000231731.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000231731.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000231742.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000231742.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000231755.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000231770.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000231770.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000231794.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000231840.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000231851.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000231858.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000231871.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000231992.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000232034.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000232085.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000232117.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000232124.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000232162.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000232164.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000232224.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000232295.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000232324.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000232354.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000232377.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000232445.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000232464.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000232480.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000232485.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000232490.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000232500.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000232527.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000232533.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000232533.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000232564.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000232636.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000232638.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000232640.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000232645.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000232648.3 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000232656.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000232725.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000232729.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000232759.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000232803.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000232874.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000232934.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000232956.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000233006.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000233013.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000233016.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000233044.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000233077.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000233080.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000233110.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000233143.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000233178.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000233203.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000233223.2 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000233293.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000233293.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000233303.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000233321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000233429.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000233479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000233483.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000233501.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000233509.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000233547.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000233554.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000233611.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000233613.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000233621.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000233627.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000233642.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000233654.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000233694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000233730.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000233775.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000233785.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000233791.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000233806.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000233825.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000233845.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000233862.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000233895.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000233912.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000233922.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000234072.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000234076.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000234111.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000234139.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000234141.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000234171.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000234185.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000234197.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000234206.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000234263.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000234264.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000234283.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000234292.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000234292.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000234327.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000234390.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000234428.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000234459.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000234476.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000234494.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000234546.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000234546.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000234572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000234584.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000234614.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000234695.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000234705.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000234705.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000234741.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000234772.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000234793.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000234807.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000234818.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000234880.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000234880.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000234917.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000234917.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000234936.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000234943.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000234945.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000234998.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000235033.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000235042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000235066.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000235077.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000235096.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000235097.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000235180.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000235189.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000235214.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000235262.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000235262.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000235269.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000235271.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000235303.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000235373.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000235410.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000235423.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000235427.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000235477.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000235527.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000235584.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000235590.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000235629.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000235641.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000235664.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000235706.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000235724.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000235724.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000235806.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000235837.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000235837.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000235897.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000235958.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000236013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000236064.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000236066.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000236095.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000236095.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000236194.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000236234.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000236269.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000236390.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000236423.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000236467.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000236514.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000236519.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000236519.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000236528.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000236540.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000236545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000236558.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000236558.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000236617.2 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000236658.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000236740.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000236819.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000236824.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000236889.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000236915.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000236938.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000236985.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000237063.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000237073.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000237074.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000237074.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000237094.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000237126.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000237187.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000237187.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000237250.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000237280.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000237298.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000237310.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000237336.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000237399.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000237410.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000237413.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000237476.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000237523.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000237523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000237525.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000237529.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000237689.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000237689.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000237689.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000237697.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000237705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000237737.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000237753.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000237753.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000237756.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000237845.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000237870.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000237877.2 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000237886.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000237903.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000237934.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000237940.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000237943.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000237943.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000238005.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000238039.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000238058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000238078.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000238113.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000238123.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000238133.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000238140.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000238140.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000238142.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000238186.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000238197.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000238221.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000238279.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000239216.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000239219.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000239300.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000239335.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000239462.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000239462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000239523.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000239593.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000239608.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000239664.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000239664.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000239664.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000239705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000239801.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000239906.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000240005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000240207.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000240211.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000240288.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000240476.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000240553.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000240591.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000240618.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000240996.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000241101.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000241125.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000241125.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000241269.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000241288.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000241313.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000241316.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000241359.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000241544.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000241570.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000241570.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000241570.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000241679.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000241764.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000241860.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000241933.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000241933.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000241985.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000241990.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000242349.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000242357.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000242396.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000242553.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000242791.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000242798.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000243069.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000243107.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000243176.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000243350.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000243368.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000243368.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000243485.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000243533.2 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000243701.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000243766.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000243960.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000244124.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000244198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000244203.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000244265.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000244380.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000244479.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000244513.2 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000244578.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000244586.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000244625.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000244757.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000245112.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000245213.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000245213.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000245275.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000245311.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000245522.2 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000245532.4 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000245534.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000245812.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000245849.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000245954.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000245975.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000246067.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000246090.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000246100.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000246130.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000246130.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000246145.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000246145.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000246225.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000246363.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000246422.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000246526.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000246526.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000246560.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000246640.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000246790.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000247081.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000247092.2 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000247095.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000247287.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000247311.2 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000247595.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000247624.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000247675.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000247735.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000248008.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000248019.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000248027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000248100.2 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000248131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000248175.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000248175.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000248228.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000248240.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000248265.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000248323.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000248367.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000248533.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000248559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000248576.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000248576.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000248599.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000248734.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000248758.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000248783.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000248787.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000248846.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000248890.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000248925.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000248936.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000249022.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000249234.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000249295.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000249352.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000249356.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000249359.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000249379.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000249379.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000249406.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000249476.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000249492.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000249635.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000249647.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000249685.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000249740.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000249786.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000249807.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000249835.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000249846.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000249846.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000249870.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000250012.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000250069.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000250116.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000250129.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000250132.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000250156.3 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000250237.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000250240.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000250343.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000250365.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000250432.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000250508.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000250511.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000250548.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000250596.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000250635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000250742.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000250742.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000250764.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000250764.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000250786.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000250893.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000250903.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000250917.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000250961.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000250986.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000251054.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000251131.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000251144.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000251148.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000251169.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000251175.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000251187.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000251221.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000251307.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000251307.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000251323.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000251365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000251370.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000251387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000251455.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000251513.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000251602.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000251603.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000251611.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000251611.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000251615.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000251867.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000253111.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000253125.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000253187.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000253197.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000253210.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000253227.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000253263.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000253302.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000253327.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000253327.2 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000253355.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000253372.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000253404.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000253539.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000253552.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000253553.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000253574.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000253582.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000253641.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000253678.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000253687.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000253754.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000253754.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000253774.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000253853.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000253898.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000253961.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000253972.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000254003.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000254028.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000254109.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000254207.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000254208.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000254246.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000254248.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000254263.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000254315.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000254409.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000254431.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000254451.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000254458.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000254459.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000254473.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000254477.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000254539.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000254592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000254605.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000254606.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000254682.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000254756.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000254812.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000254812.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000254821.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000254911.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000254973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000254985.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000254985.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000254987.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000254990.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000255031.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000255045.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000255052.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000255052.3 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000255135.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000255165.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000255176.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000255191.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000255234.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000255237.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000255237.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000255248.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000255326.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000255334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000255337.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000255435.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000255471.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000255474.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000255503.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000255568.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000255651.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000255669.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000255689.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000255741.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000255893.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000255933.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000255992.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000256006.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000256092.2 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000256164.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000256248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000256433.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000256448.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000256481.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000256564.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000256633.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000256712.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000256714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000256789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000256789.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000256862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000256897.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000256967.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000257048.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000257052.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000257052.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000257058.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000257137.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000257183.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000257202.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000257252.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000257256.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000257261.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000257264.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000257285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000257298.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000257329.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000257543.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000257551.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000257557.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000257557.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000257563.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000257568.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000257596.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000257612.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000257702.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000257702.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000257742.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000257808.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000257824.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000257831.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000257924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000257964.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000257999.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000257999.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000258034.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000258044.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000258044.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000258096.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000258099.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000258101.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000258101.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000258101.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000258137.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000258181.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000258181.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000258303.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000258317.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000258323.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000258325.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000258378.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000258413.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000258425.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000258428.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000258443.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000258450.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000258455.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000258520.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000258558.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000258602.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000258620.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000258633.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000258649.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000258658.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000258717.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000258725.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000258766.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000258793.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000258798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000258844.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000258903.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000258914.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000258926.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000258929.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000258929.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000258940.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000258940.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000258940.2 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000258952.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000258959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000258982.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000259002.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000259002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000259071.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000259118.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000259153.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000259153.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000259182.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000259218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000259242.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000259250.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000259250.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000259287.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000259298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000259319.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000259322.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000259343.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000259351.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000259353.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000259364.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000259364.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000259372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000259408.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000259438.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000259439.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000259442.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000259453.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000259469.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000259473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000259474.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000259475.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000259532.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000259536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000259553.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000259563.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000259584.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000259623.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000259654.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000259654.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000259668.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000259678.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000259682.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000259717.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000259724.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000259727.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000259732.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000259768.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000259783.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000259796.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000259797.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000259797.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000259802.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000259802.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000259828.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000259863.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000259871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000259876.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000259877.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000259883.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000259901.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000259915.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000259925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000260006.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000260006.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000260008.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000260025.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000260035.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000260038.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000260052.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000260060.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000260060.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000260065.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000260084.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000260086.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000260118.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000260123.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000260136.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000260156.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000260173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000260186.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000260194.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000260194.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000260213.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000260219.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000260261.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000260278.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000260279.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000260281.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000260281.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000260288.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000260310.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000260328.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000260329.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000260352.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000260360.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000260377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000260388.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000260396.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000260440.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000260447.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000260466.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000260468.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000260488.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000260495.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000260507.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000260519.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000260528.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000260534.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000260545.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000260581.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000260583.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000260618.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000260630.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000260633.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000260641.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000260646.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000260671.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000260672.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000260698.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000260704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000260743.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000260805.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000260805.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000260814.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000260837.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000260920.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000260931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000260936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000260941.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000260954.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000260955.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000260955.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000260986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000260992.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000261024.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000261068.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000261083.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000261096.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000261096.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000261101.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000261131.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000261167.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000261172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000261195.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000261220.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000261235.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000261254.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000261280.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000261291.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000261295.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000261298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000261341.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000261394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000261396.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000261428.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000261431.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000261433.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000261438.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000261469.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000261469.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000261478.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000261485.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000261523.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000261526.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000261534.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000261544.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000261572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000261578.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000261616.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000261632.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000261673.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000261712.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000261723.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000261731.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000261775.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000261777.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000261777.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000261783.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000261783.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000261798.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000261823.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000261886.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000262152.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000262152.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000262185.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000262202.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000262228.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000262292.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000262298.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000262343.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000262362.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000262412.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000262619.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000262652.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000262703.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000262833.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000262837.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000262979.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000263004.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000263004.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000263050.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000263325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000263345.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000263370.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000263412.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000263470.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000263531.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000263627.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000263680.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000263709.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000263709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000263718.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000263753.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000263860.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000263860.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000263924.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000263931.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000264080.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000264107.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000264188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000264365.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000264365.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000264577.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000264785.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000264808.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000264812.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000264829.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000264920.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000264968.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000265008.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000265010.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000265055.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000265094.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000265337.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000265458.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000265478.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000265478.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000265496.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000265656.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000265656.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000265749.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000266049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000266088.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000266126.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000266126.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000266176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000266304.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000266441.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000266450.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000266469.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000266644.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000266677.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000266709.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000266801.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000266801.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000266805.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000266844.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000266900.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000266900.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000266921.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000266933.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000266941.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000266941.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000266947.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000266955.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000266970.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000266994.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000267015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000267018.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000267024.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000267073.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000267080.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000267093.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000267151.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000267161.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000267167.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000267219.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000267221.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000267222.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000267232.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000267263.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000267274.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000267274.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000267289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000267316.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000267321.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000267325.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000267348.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000267348.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000267375.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000267405.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000267414.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000267454.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000267462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000267476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000267479.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000267501.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000267501.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000267532.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000267567.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000267583.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000267658.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000267715.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000267729.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000267730.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000267730.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000267751.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000267751.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000267764.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000267764.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000267783.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000267798.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000267798.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000267804.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000267838.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000267871.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000267939.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000267940.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000268015.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000268049.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000268049.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000268081.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000268095.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000268095.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000268230.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000268307.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000268307.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000268316.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000268366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000268392.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000268516.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000268543.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000268543.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000268549.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000268568.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000268650.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000268756.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000268756.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000268836.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000268970.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000268970.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000269044.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000269051.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000269066.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000269172.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000269172.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000269235.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000269246.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000269289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000269293.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000269303.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000269386.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000269392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000269397.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000269397.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000269444.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000269444.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000269473.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000269483.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000269524.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000269553.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000269560.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000269614.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000269836.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000269900.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000269901.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000269903.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000269942.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000269956.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000269959.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000269962.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000269966.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000269973.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000269979.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000269983.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000269983.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000269997.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000270028.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000270041.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000270049.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000270055.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000270062.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000270067.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000270076.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000270091.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000270095.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000270100.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000270102.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000270103.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000270103.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000270133.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000270137.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000270140.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000270157.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000270157.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000270159.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000270173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000270265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000270302.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000270361.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000270462.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000270589.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000270607.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000270681.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000270755.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000270933.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000270988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000271020.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000271119.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000271335.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000271384.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000271538.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000271538.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000271553.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000271554.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000271576.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000271646.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000271752.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000271757.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000271762.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000271780.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000271782.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000271824.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000271833.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000271835.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000271840.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000271843.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000271862.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000271862.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000271869.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000271871.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000271888.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000271912.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000271912.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000271913.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000271926.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000271947.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000271963.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000271964.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000271975.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000271981.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272004.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000272005.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000272005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000272009.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272029.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000272030.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000272040.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272048.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000272065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000272071.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000272071.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000272077.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272079.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000272079.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272081.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000272081.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000272121.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000272123.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272137.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272138.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000272144.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272144.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000272148.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000272198.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000272205.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000272211.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lestaurtinib |
ENSG00000272217.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000272264.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000272273.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000272320.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000272320.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272335.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000272338.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000272338.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000272354.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000272365.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000272369.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000272370.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000272370.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272373.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000272382.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000272386.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000272403.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000272432.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000272432.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000272440.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272444.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000272446.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000272447.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000272452.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272455.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000272457.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000272468.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000272468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000272468.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272489.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000272498.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000272508.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000272537.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272554.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000272558.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000272558.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000272567.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000272567.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000272576.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272604.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272604.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272610.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000272645.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000272650.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000272659.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000272682.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000272682.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000272688.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272689.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000272695.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000272699.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272702.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272715.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000272716.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000272744.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000272760.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000272780.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000272787.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000272796.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272829.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000272829.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000272862.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000272864.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000272913.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000272945.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000272970.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000272979.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000273002.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000273011.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000273027.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000273038.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000273038.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000273061.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000273069.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000273081.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000273097.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000273125.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000273145.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000273162.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000273176.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000273183.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000273183.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000273186.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000273186.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000273186.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000273190.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000273237.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000273240.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000273284.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000273289.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000273290.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000273295.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000273297.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000273297.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000273306.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000273306.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000273306.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lestaurtinib |
ENSG00000273308.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000273319.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000273342.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lestaurtinib |
ENSG00000273344.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lestaurtinib |
ENSG00000273365.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000273373.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lestaurtinib |
ENSG00000273375.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lestaurtinib |
ENSG00000273445.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000273449.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lestaurtinib |
ENSG00000273451.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000273454.1 |
Predicted lncRNA |
Sarcoma |
|
| Lestaurtinib |
ENSG00000273474.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lestaurtinib |
ENSG00000273483.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Lestaurtinib |
ENSG00000273483.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lestaurtinib |
ENSG00000273483.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|